The first ICU Medical trade was made in Q2 2021.
Since then Ray Dalio bought shares five more times and sold shares on ten occasions. The investor completely sold their stake between Q1 2024 and Q1 2025.
Avg closing price
Price range
Sold -2.42 Thousand shares
Q1 2025
Avg closing price
$155.51
Price range
$130.05
-
$172.30
Sold 30.3% shares (-1.05 Thousand shares)
Q4 2024
Avg closing price
$168.65
Price range
$154.20
-
$183.83
Sold 8.6% shares (-324 shares)
Q3 2024
Avg closing price
$147.86
Price range
$114.88
-
$182.22
Sold 18.1% shares (-836 shares)
Q2 2024
Avg closing price
$105.21
Price range
$94.53
-
$120.55
Sold 79.5% shares (-17.9 Thousand shares)
Q1 2024
Avg closing price
$99.43
Price range
$86.88
-
$112.48
Increased shares by 372.9% (+17.8 Thousand shares)
Q4 2023
Avg closing price
$97.78
Price range
$81.08
-
$119.29
Sold 77.2% shares (-16.1 Thousand shares)
Q3 2023
Avg closing price
$149.21
Price range
$115.27
-
$182.23
Sold 18.5% shares (-4.74 Thousand shares)
Q2 2023
Avg closing price
$183.48
Price range
$161.03
-
$209.15
Increased shares by 6.8% (+1.62 Thousand shares)
Q1 2023
Avg closing price
$172.03
Price range
$153.15
-
$198.21
Sold 23.8% shares (-7.49 Thousand shares)
Q4 2022
Avg closing price
$152.18
Price range
$136.41
-
$165.56
New holding (+31.5 Thousand shares)
Q3 2022
Avg closing price
$166.37
Price range
$149.44
-
$188.10
Sold -32.4 Thousand shares
Q2 2022
Avg closing price
$192.51
Price range
$161.40
-
$229.70
Increased shares by 46.6% (+10.3 Thousand shares)
Q1 2022
Avg closing price
$224.01
Price range
$203.51
-
$247.46
Increased shares by 12.7% (+2.5 Thousand shares)
Q4 2021